The TCR showed specific recognition and lysis of primary AMLs in vitro upon transfer to CD8 cells, but failed to induce an anti-tumor response in immunodeficient NSG mice engrafted with dNPM1 OCI-AML3 cells. This evidence concerns the gene CD8A and neoplasm.